Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth?

The Diageo share price has almost halved since peaking in late 2021. But with the stock at a one-year low, I expect a rebound ...

Harvey Jones loves his FTSE 100 dividend income shares but was disappointed by the lack of growth. Now it looks like that may ...

FTSE AIM stock Jet2 appears to be a bargain in plain sight. I’m desperately searching for reasons not to buy this stock, but ...

Warnings of weak economic growth, resurgent inflation, and falling interest rates pose a toxic cocktail for Lloyds' share ...

The Bank of England's latest meeting has fed speculation of swingeing interest rate cuts. I think these UK shares could soar in this scenario.

FTSE 100 heavyweight AstraZeneca helped propel the blue-chip index to a record high today. Here's what investors were ...

As interest on cash savings becomes increasingly less attractive, Paul Summers has been looking at dividend growth shares for ...

Babcock International's flying after upgrading its full-year forecasts. I think the FTSE 250 defence share might just be ...

Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...

A big step up in AI spending at Google has investors nervous, but has it created an opportunity to buy its shares at an ...

Mark David Hartley considers how investors could build towards an early retirement plan with a second income from a portfolio ...